We want to introduce you to Dr Thierry Jardé, a member of Phenomics Australia’s Scientific Director’s team and Director of the Monash Organoid Program at Monash University.
Meet Thierry:
Dr Thierry Jardé is the Director of the Monash Organoid Program at the Monash Biomedicine Discovery Institute, an In Vitro Genome Engineering and Disease Modelling node of Phenomics Australia. He collaborates with clinicians to grow organoids from human breast and gastrointestinal tissues. These organoids are currently being used for a variety of biological studies, including drug testing.
Thierry is also a Laboratory Head in the Department of Anatomy and Developmental Biology at Monash University. He is a cancer cell biologist who has worked for the last 15 years with organoids and mouse models to study stem cell function in health and disease.
He completed his doctoral studies at the School of Pharmacy (Clermont-Ferrand) in France before conducting postdoctoral training under the supervision of Professor Trevor Dale at the School of Biosciences (Cardiff University, UK) and Professor Helen Abud at the Biomedicine Discovery Institute (Monash University) where he studied the role of WNT and NRG1 signalling in stem cell biology.
“Phenomics Australia supports world-class infrastructures and the development of cutting-edge technologies, enabling research excellence in Australia. Within the In Vitro Genome Engineering and Disease Modelling node, the Monash Organoid Program helps Scientists around the Country generate novel in vitro organoid models, by producing key cell culture reagents, assisting with organoid establishment, performing a wide range of assays for phenotypic characterisation and training the future generation of research leaders. “ Dr Jardé said.
Monash Organoid Program
Monash Organoid Program’s world-class organoid research utilises cutting-edge techniques to generate 3D “mini-organ” models to study development and disease. They facilitate the work of world-leading researchers in infectious disease, stem cell biology and personalised cancer medicine to improve outcomes for patients.
Services:
• In vitro Genome Engineering and Disease Modelling
Monash Organoids Program in action:
Video footage of Organoids and Scientists working at the Monash Organoid Program with video credits to Monash Organoid Program
Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers In Vitro services through a collaborative consortium of ten laboratories and facilities across Australia, operating at ANU (ANU Centre for Therapeutic Discovery), Perkins (Translational Cancer Research Program in Oncology), Monash (Monash Organoid Program & Monash Genome Modification Platform), MCRI (iPSC derivation & Gene Editing Facility), Peter Mac (Victorian Centre for Functional Genomics), UMelb (Centre for Stem Cell Systems & Stem Cell Disease Modelling Laboratory), UQ (In vitro Genome Engineering and Disease Modelling Service), and VCCRI (Stem Cell Production Facility iPSC Reprogramming Service)
